Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Change in Accured Expenses (2020 - 2025)

Bio Essence has reported Change in Accured Expenses over the past 6 years, most recently at -$306245.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 9853.03% year-over-year to -$306245.0; the TTM value through Dec 2025 reached -$302037.0, down 250.69%, while the annual FY2025 figure was -$302037.0, 250.69% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$306245.0 at Bio Essence, down from $5513.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $377931.0 in Q3 2021 and troughed at -$490796.0 in Q2 2021.
  • A 5-year average of -$30029.9 and a median of -$18.0 in 2024 define the central range for Change in Accured Expenses.
  • On a YoY basis, Change in Accured Expenses climbed as much as 137725.0% in 2025 and fell as far as 9853.03% in 2025.
  • Year by year, Change in Accured Expenses stood at -$337578.0 in 2021, then soared by 99.63% to -$1233.0 in 2022, then surged by 83.37% to -$205.0 in 2023, then skyrocketed by 1631.71% to $3140.0 in 2024, then tumbled by 9853.03% to -$306245.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for BIOE at -$306245.0 in Q4 2025, $5513.0 in Q3 2025, and -$1287.0 in Q2 2025.